Kristine Marie Ward, MD

Hematology, Medical Oncology
Accepting new patients
Sees patients age 18 and up
Penn Hematology/Oncology Pennsylvania Hospital
View 1 additional location
Headshot of Kristine Marie Ward, MD
Penn Medicine Provider

About me

  • Clinical Assistant Professor of Medicine (Hematology-Oncology)

My education and training

  • Medical School: Thomas Jefferson University
  • Residency: Lankenau Medical Center
  • Residency: Pennsylvania Hospital
  • Fellowship: Drexel University College of Medicine

Spoken languages

English
English

Insurance accepted

Please contact the practice and/or the member services department of your insurance company for specific details before receiving services. Providers may participate in some, but not all, products offered by a health plan; providers may also accept plans at some practice locations but not others.

Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Pennsylvania Hospital: Has privileges to treat patients in the hospital.
Dr. Ward is a Penn Medicine physician.

Qualifications and experience

Treatments and conditions

Research

Publications

Hugo Lara- Martinez, Kristine Ward Michael Styler, Praneeth Baratam Angiosarcoma of the Face: A Case Study and Literature Review of Local and Metastatic Angiosarcoma , Case Reports in Oncological Medicine , 2021: 2021


S Bukhari Kristine Ward Michael Styler Hepatocellular Carcinoma First Manifestation as Solitary Humeral Bone Metastasis , Case Reports in Oncological Medicine : 2020


Ronak Mistry Kristine Ward Sickle Induced Cholestasis: A Rare but Fatal Complication of Sickle Cell Disease , PA ACP Southeastern Chapter Abstract # 31: 2020


Wilbur Bowne, Michael J Styler Kristine Ward targeting membrane HDM 2 by PNC 27 Induces Necrosis in leukemia Cells but not in normal Hematopoietic Cells , Anticancer Research , 40(9): 2020,4857-4867


Kyung D, Perimbeti S, Adepoju B, Hanson S, McCormack M, Ward K, Jain M, Styler M Relationship between underlying causes of HCC and its complications , J Clin Oncol: 2019


Bemis T, Baratam P, Seiders D, Ward K, Styler M Impact of timing of palliative care team consults in patients with advanced cancer , J Clin Oncol: 2019


Perimbeti S, Shrivastav R, Stanchina M, Pathak P, Rainone M, Jain M, Ward K, Styler M Trends in mortality due to hypercalcemia in breast cancer. , J Clin Oncol: 2019


Perimbeti S, Shrivastav R, Jatwani K, Ward K, Styler M, Jain M, Nandi N Impact of Clostridium difficile infection on gastrointestinal malignancies , J Clin Oncol: 2019


Gleeson EM, Feldman R, Mapow BL, Mackovick LT, Ward KM, Morano WF, Rubin RR, Bowne WB. Appendix-derived Pseudomyxoma Peritonei (PMP): Molecular Profiling Toward Treatment of a Rare Malignancy. , Am J Clin Oncol., 41(8): 2018,777-783


Schmalz L, Trisel Z, Perimbeti S, Lee W, Topolsky D, Crilley P, Ward K, Styler M Malignant pleural effusions: Do race, obesity and comorbidities play a role? , J Clin Oncol: 2018